Takeda expands into Canada

Japan-based Takeda Pharmaceutical Company Limited and its wholly owned subsidiary, Takeda Pharmaceuticals North America, have established Takeda Canada, expanding the company’s North American presence. Takeda Canada will be headquartered in Mississauga, Ontario.

Daaron Dohler will serve as the general manager and president of the new entity as of April 1, 2009. Mr Dohler’s recent responsibilities at Takeda have included leading Takeda’s global alliance research department and creating Takeda’s global alliance management organization.

During his career in the pharmaceutical industry, Mr Dohler has worked in a variety of different roles including marketing, business development, new drug development, and operations.

Takeda Canada will register and commercialize medicines from Takeda’s portfolio of primary care and specialty products. Takeda Canada intends to file its first new drug submission with the Canadian Health Authority by the end of 2009.

Yasuchika Hasegawa, president of Takeda, said: Aiming to realize itself as a world-class pharmaceutical company, Takeda is striving to reinforce a global operating infrastructure including expanding its own sales channels. Takeda’s entrance into Canada is a significant step in expanding Takeda’s North American presence. Takeda Canada’s primary goal will be to help bring important medicines to the patients in Canada who need them.